US Patent 8617571 Suture line administration technique using botulinum toxin
Patent 8617571 was granted and assigned to Allergan, Inc. on December, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8617571 Suture line administration technique using botulinum toxin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
